Upload Avatar (500 x 500)
Lishuang Qi
qilishuang7@ems.hrbmu.edu.cn
Chinese, English
Heilongjiang
Harbin Medical University
College of Bioinformatics Science and Technology
  • 2017-09 to Present - Harbin Medical University - Associate Professor
  • 2014-07 to 2016-09 - Harbin Medical University - Lecturer
  • 2022: National Invention Patent for Cancer Clinical Indicator Evaluation System
  • 2021: National Key Field Project, Student Innovation and Entrepreneurship Training Program
  • 2020: Second Prize in Heilongjiang Province Medical and Health Science and Technology
  • 2017: Third Prize in Heilongjiang Province Science and Technology Award
  • 2016: Third Prize in Harbin Science and Technology Progress Award
Lung Cancer Systems Biology and Clinical Translational Research
  • A genetic map of the chromatin regulators to drug response in cancer cells., Bo Chen, Pengfei Li, Mingyue Liu, Kaidong Liu, Min Zou, Yiding Geng, Shuping Zhuang, Huanhuan Xu, Linzhu Wang, Tingting Chen, Yawei Li, Zhangxiang Zhao, Lishuang Qi, Yunyan Gu, 2022
  • Identifying metabolic reprogramming phenotypes with glycolysis-lipid metabolism discoordination and intercellular communication for lung adenocarcinoma metastasis., Xin Li, Lefan Tang, Jiaxing Deng, Xiuying Qi, Juxuan Zhang, Haitao Qi, Mengyue Li, Yixin Liu, Wenyuan Zhao, Yunyan Gu, Lishuang Qi, Xia Li, 2022
  • Predicting Chemo-Radiotherapy Sensitivity With Concordant Survival Benefit in Non-Small Cell Lung Cancer via Computed Tomography Derived Radiomic Features., Yixin Liu, Haitao Qi, Chunni Wang, Jiaxing Deng, Yilong Tan, Lin Lin, Zhirou Cui, Jin Li, Lishuang Qi, 2022
  • Hierarchical identification of a transcriptional panel for the histological diagnosis of lung neuroendocrine tumors., Juxuan Zhang, Jiaxing Deng, Xiao Feng, Yilong Tan, Xin Li, Yixin Liu, Mengyue Li, Haitao Qi, Lefan Tang, Qingwei Meng, Haidan Yan, Lishuang Qi, 2022
  • Reference genome and annotation updates lead to contradictory prognostic predictions in gene expression signatures: a case study of resected stage I lung adenocarcinoma., Zheyang Zhang, Sainan Zhang, Xin Li, Zhangxiang Zhao, Changjing Chen, Juxuan Zhang, Mengyue Li, Zixin Wei, Wenbin Jiang, Bo Pan, Ying Li, Yixin Liu, Yingyue Cao, Wenyuan Zhao, Yunyan Gu, Yan Yu, Qingwei Meng, Lishuang Qi, 2021
  • Identifying 18F-FDG PET-metabolic radiomic signature for lung adenocarcinoma prognosis via the leveraging of prognostic transcriptomic module., Yixin Liu, Jin Li, Wenlei Dong, Yang Zhou, Kuan Luan, Lishuang Qi, 2022
  • The value of AGR2 and KRT5 as an immunomarker combination in distinguishing lung squamous cell carcinoma from adenocarcinoma., Bo Pan, Zi Xin Wei, Ju Xuan Zhang, Xin Li, Qing Wei Meng, Ying Yue Cao, Lishuang Qi, Yan Yu, 2021
  • A qualitative transcriptional signature of recurrence risk for stages II–III gastric cancer patients after surgical resection., Huarong Zhang, Xiangyu Li, Junling Wu, Jiahui Zhang, Haiyan Huang, Yawei Li, Meifeng Li, Shanshan Wang, Jie Xia, Lishuang Qi, Ting Chen, Lu Ao, 2021
  • Identification of Genes Universally Differentially Expressed in Gastric Cancer., Yidan Shi, Lishuang Qi, Haifeng Chen, Jiahui Zhang, Qingzhou Guan, Jun He, Meifeng Li, Zheng Guo, Haidan Yan, Ping Li, 2021
  • Identification of a small mutation panel of coding sequences to predict the efficacy of immunotherapy for lung adenocarcinoma., Ying Li, Wenbin Jiang, Tianhao Li, Mengyue Li, Xin Li, Zheyang Zhang, Sainan Zhang, Yixin Liu, Wenyuan Zhao, Yunyan Gu, Lishuang Qi, Lu Ao, Zheng Guo, 2020
  • A qualitative transcriptional signature for predicting microsatellite instability status of right-sided Colon Cancer., Yelin Fu, Lishuang Qi, Wenbing Guo, Liangliang Jin, Kai Song, Tianyi You, Shuobo Zhang, Yunyan Gu, Wenyuan Zhao, Zheng Guo, 2019
  • A qualitative transcriptional signature for the histological reclassification of lung squamous cell carcinomas and adenocarcinomas., Xin Li, Gengen Shi, Qingsong Chu, Wenbin Jiang, Yixin Liu, Sainan Zhang, Zheyang Zhang, Zixin Wei, Fei He, Zheng Guo, Lishuang Qi, 2019
  • A Qualitative Transcriptional Signature for Predicting Recurrence Risk for High-Grade Serous Ovarian Cancer Patients Treated With Platinum-Taxane Adjuvant Chemotherapy., Yixin Liu, Zheyang Zhang, Tianhao Li, Xin Li, Sainan Zhang, Ying Li, Wenyuan Zhao, Yunyan Gu, Zheng Guo, Lishuang Qi, 2019
  • Individualized analysis of differentially expressed miRNAs with application to the identification of miRNAs deregulated commonly in lung cancer tissues., Haidan Yan, Hao Cai, Qingzhou Guan, Jun He, Juan Zhang, You Guo, Haiyan Huang, Xiangyu Li, Yawei Li, Yunyan Gu, Lishuang Qi, Zheng Guo, 2018
  • An individualized gene expression signature for prediction of lung adenocarcinoma metastases., Lishuang Qi, Tianhao Li, Gengen Shi, Jiasheng Wang, Xin Li, Sainan Zhang, Libin Chen, Yuan Qin, Yunyan Gu, Wenyuan Zhao, Zheng Guo, 2017
  • Critical limitations of prognostic signatures based on risk scores summarized from gene expression levels: a case study for resected stage I non-small-cell lung cancer., Lishuang Qi, Libin Chen, Yang Li, Yuan Qin, Rufei Pan, Wenyuan Zhao, Yunyan Gu, Hongwei Wang, Ruiping Wang, Xiangqi Chen, Zheng Guo, 2016
  • An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy., Lishuang Qi, Yang Li, Yuan Qin, Gengen Shi, Tianhao Li, Jiasheng Wang, Libin Chen, Yunyan Gu, Wenyuan Zhao, Zheng Guo, 2016
Lung Cancer Systems Biology Clinical Research Translational Research Biomarkers Metastasis Drug Resistance Genomics Bioinformatics Cancer Therapy

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.